Roche Wins First Indian Product Patent

Law360, New York (March 6, 2006, 12:00 AM EST) -- Swiss drug maker F. Hoffmann-La Roche has become the first pharmaceutical company in India to win a product patent under the country’s new patent regime, receiving approval for its hepatitis C drug Pegasys.

The company’s Indian subsidiary, Roche India Pvt Ltd, said its product patent will be valid for 20 years, starting from May 15, 1997, giving the company exclusive selling rights within India for the next eleven years.

According to Roche, Pegasys “provides significant benefits over conventional combination interferon therapy in hepatitis C patients of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.